SGEN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SGEN Shares Outstanding History and SGEN YTD Return |
SGEN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: SGEN Shares Outstanding History and SGEN YTD Return |
SGEN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+29.59% CAGR Mouse over chart for data details
|
SGEN Stock Price Chart |
About Seagen Inc |
Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TUKYSA®, or tucatinib, for the treatment of certain metastatic HER2-positive breast and colorectal cancers, and TIVDAK®, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients. We show 56 historical shares outstanding datapoints in our SGEN shares outstanding history coverage, used to compute SGEN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SGEN market cap history over the course of time is important for investors interested in comparing SGEN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SGEN versus a peer is one thing; comparing SGEN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SGEN can fluctuate over the course of history. With this page we aim to empower investors researching SGEN by allowing them to research the SGEN market cap history. |
SGEN Current Stock Quote |
Free SGEN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SGEN Share Performance |
Market Cap Peers |
Seattle Genetics (SGEN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SGFY Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.